• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . All‑cause excess mortality in Germany peaked during the late‑2022 influenza period, exceeding peaks during SARS‑CoV‑2 waves (2020-2023)

tetano

Editor, Senior Moderator
PLoS One


. 2026 Jun 17;21(6):e0335982.
doi: 10.1371/journal.pone.0335982. eCollection 2026.
All‑cause excess mortality in Germany peaked during the late‑2022 influenza period, exceeding peaks during SARS‑CoV‑2 waves (2020-2023)

Ursel Heudorf[SUP] 1 [/SUP], Bernd Kowall[SUP] 2 [/SUP]


Affiliations
Abstract

Introduction: Numerous studies have examined mortality during the SARS-CoV-2 pandemic in Germany and worldwide. In Germany, excess mortality was highest in 2022 compared to the other pandemic years. In a small-scale analysis in Frankfurt am Main, Germany, the excess mortality 2022 was associated with an influenza wave at the end of the year. The aim of this study was to investigate this for the whole of Germany.
Methods: We used publicly available data for the number of deaths, for the population data and for notifications of SARS-CoV-2 and influenza. Standardized mortality ratios (SMR) were estimated for Germany for the years 2020-2023, for seven SARS-CoV-2 waves and for the influenza wave at the end of 2022. Expected numbers of deaths were estimated by two methods: in the first, average mortality in the pre-pandemic years 2016-2019 was used; in the latter, an exponential extrapolation was used to consider the increase in life expectancy.
Results: Relative excess mortality was highest in 2022 (SMR = 1.069 (95% confidence interval: 1.066-1.071) by method 1, SMR = 1.094 (1.092-1.096) by method 2). During the influenza wave from calendar week 47 / 2022 to calendar week 1 / 2023, the SMR was higher than that of any SARS-CoV-2 wave: SMR = 1.252 (95% CI: 1.246-1.258) by method 1, and SMR = 1.374 (95% CI: 1.367-1.380) by method 2. Among all waves considered, the mean number of excess deaths per week was highest during the influenza wave by both methods (5,043, and 6,812, respectively). Age-stratified analyses showed that the excess mortality during the influenza wave at the end of 2022 was highest in individuals aged 70 years and older.
Discussion: During an influenza wave at the end of 2022, excess mortality was higher than in any SARS-CoV-2 wave in 2020-2022 in Germany. Because this study is based on all‑cause mortality and population‑level surveillance indicators, it cannot establish causation or quantify the proportion of excess deaths directly attributable to influenza infection.


 
Back
Top